The Institute for Genomic Research

The Institute for Genomic Research (TIGR) was a non-profit research institute located in Rockville, Maryland, United States. It was founded in 1992 by J. Craig Venter and Claire M. Fraser after they left the National Institutes of Health. The institute was involved in various sequencing projects, including the sequencing of the genomes of various bacteria, plants, and parasites. In 2006, TIGR was integrated into the J. Craig Venter Institute (JCVI).

History[edit | edit source]

TIGR was founded in 1992 by J. Craig Venter and Claire M. Fraser. The institute was initially funded by a grant from the Ventner Foundation. The first project undertaken by TIGR was the sequencing of the genome of the bacterium Haemophilus influenzae, which was completed in 1995. This was the first time the complete genome of a free-living organism had been sequenced.

In 2002, TIGR and the Institute for Biological Energy Alternatives (IBEA) were the first to sequence the genome of a bacterium that uses arsenic to survive. In 2004, TIGR sequenced the genome of the bacterium Bacillus anthracis, the causative agent of anthrax.

In 2006, TIGR was integrated into the J. Craig Venter Institute (JCVI), a new research organization also founded by Venter.

Research[edit | edit source]

TIGR conducted research in various areas of genomics, including the sequencing of the genomes of various bacteria, plants, and parasites. The institute also developed various bioinformatics tools and databases to aid in the analysis of genomic data.

Notable people[edit | edit source]

J. Craig Venter, co-founder
Claire M. Fraser, co-founder
Hamilton O. Smith, Nobel laureate and former director of the institute

References[edit | edit source]

External links[edit | edit source]

Official website

The Institute for Genomic Research Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.